[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335987-105":59,"doc-detail-335987-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","current-state-of-knowledge-on-blood-and-tissue-based-biomarkers-for-opisthorchis-viverrini-induced-cholangiocarcinoma-a-review-of-prognostic-predictive-and-diagnostic-markers","Current State of Knowledge on Blood and Tissue-Based Biomarkers for Opisthorchis viverrini-induced Cholangiocarcinoma - A Review of Prognostic, Predictive, and Diagnostic Markers","","Cholangiocarcinoma (CCA) is a prevalent cancer in Southeast Asia, with Opisthorchis viverrini infection as a primary risk factor. Most cases are diagnosed at advanced stages, resulting in unfavorable prognoses. This review highlights the importance of stage-specific biomarkers for Opisthorchis viverrini-induced cholangiocarcinoma (OvCCA) to enable earlier detection and more timely, curative interventions, reducing morbidity and mortality. It summarizes worm- and host-related molecular biomarkers and evaluates their prognostic, predictive, and diagnostic value, including progress via multiomics approaches.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/current-state-of-knowledge-on-blood-and-tissue-based-biomarkers-for-opisthorchis-viverrini-induced-cholangiocarcinoma-a-review-of-prognostic-predictive-and-diagnostic-markers/335987/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/current-state-of-knowledge-on-blood-and-tissue-based-biomarkers-for-opisthorchis-viverrini-induced-cholangiocarcinoma-a-review-of-prognostic-predictive-and-diagnostic-markers/335987.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are stage-specific biomarkers important for Opisthorchis viverrini-induced cholangiocarcinoma?","Question",{"text":112,"@type":113},"Stage-specific biomarkers support early detection and help monitor therapy effectiveness, enabling timely curative interventions and adjustments to reduce high morbidity and mortality.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What causes most cholangiocarcinoma cases in the region to be diagnosed at advanced stages?",{"text":117,"@type":113},"The document links advanced diagnosis and poor prognosis to the prevalent high-risk environment created by liver fluke infection, with progression driven by long-term infection and inflammation.",{"name":119,"@type":110,"acceptedAnswer":120},"What types of biomarkers does the review discuss for OvCCA?",{"text":121,"@type":113},"The review discusses potential O. viverrini-specific molecular biomarkers for diagnosis and monitoring, including both worm-induced and host-induced factors, and evaluates their prognostic, predictive, and diagnostic roles.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335987,1790838749,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","REVIEW  \nEditorial Process: Submission:09/04/2023 Acceptance:01/19/2024  \nCurrent State of Knowledge on Blood and Tissue-Based Biomarkers for Opisthor chis v iverrini-induced Cholangiocarcinoma: AReview of Prognostic, Predictive, and Diagnostic Markers  \nAlok Kafle1, Sutas Suttiprapa1,2 *  \nAbstract  \nCholangiocarcinoma (CCA) is a prevalent cancer in Southeast Asia, with Opisthorchis viverrini (O.viverrini) infection being the primary risk factor. Most CCA cases in this region are diagnosed at advanced stages, leading to unfavorable prognoses. The development of stage-specific biomarkers for Opisthorchis viverrini-induced cholangiocarcinoma (OvCCA) holds crucial significance, as it facilitates early detection and timely administration of curative interventions, effectively mitigating the high morbidity and mortality rates associated with this disease in the Great Mekong region. Biomarkers are a promising approach for early detection, prognosis, and targeted treatment of CCA. Disease-specific biomarkers facilitate early detection and enable monitoring of therapy effectiveness, allowing for any necessary corrections. This review provides an overview of the potential O. viverrini-specific molecular biomarkers and important markers for diagnosing and monitoring Ov-CCA, discussing their prognostic, predictive, and diagnostic value. Despite the limited research in this domain, several potential biomarkers have been identified, encompassing both worm-induced and host-induced factors. This review offers a thorough examination of historical and contemporary progress in identifying biomarkers through multiomics techniques, along with their potential implications for early detection and treatment.  \nKeywords: Cholangiocarcinoma-Opisthorchis viverrini-opisthorchiasis-biological markers-prognosis  \nAsian Pac J Cancer Prev, 25 (1), 25-41  \nIntroduction  \nIn the Greater Mekong subregion of Southeast Asia, O. viverrini causes live fluke-induced opisthorchiasis, which increases mortality rates associated with CCA [1] . In Thailand and other parts of Southeast Asia, CCA ranks as one of the most common cancers in males and females (96 per 100,000 men in Northeast Thailand) due to the high prevalence of liver fluke infection [2] . One main reason is having strong livelihoods and lifestyle associations within wetland ecosystems in the Mekong region, which are intricately related to human raw food consumption. The basin covers a large part of northeastern Thailand, almost the entire countries of Lao PDR and Cambodia [3, 4](Figure 1A), where the custom of consuming raw fish exists (Figure 1B, D), which may have been contaminated with O. viverrini metacercaria [5, 6] . Afluke can settle in the small ducts ofthe intrahepatic bile ducts and live therefor an average of 20–30 years (Figure 1C) [7]. Long-term O. viverrini infection causes bile duct inflammation, which leads to epithelial hyperplasia, periductal fibrosis, bile duct  \ndilation, and, eventually, cancer [7] .  \nAccording to the International Agency for Research on Cancer (IARC), opisthorchiasis, one of only three eukaryotic diseases classified as Group 1 carcinogens, can cause persistent inflammation in the biliary tract, causing cancer [8] . Chronic obstruction of bile ducts by flukes, mechanical damage caused by their suckers, the release of their excretory/secretory products, and immunopathology have all been noted as risk factors for the development of O. viverrini-associated CCA [9, 5, 10] . Intrahepatic cholangiocarcinoma (iCCA) is the most frequently diagnosed liver cancer subtype in places with a high prevalence of liver fluke infection, such as Northern Thailand. This is primarily due to a prototypical inflammatory etiology of liver fluke disease (Figure 1D) [11, 12] . Flukes normally reside in the small to medium intrahepatic bile ducts (IHCC), but in severe infections, they may also settle in the gallbladder and extrahepatic ducts (EHCC), which ultimately raises the risk of extrahe","cbCaisEk0vH1nLvR","https://ap.wps.com/l/cbCaisEk0vH1nLvR","pdf",1043636,17,"English","# Editorial Process\n## Submission and Acceptance\n# Abstract\n# Keywords\n# Introduction\n## Epidemiology and Transmission Dynamics\n## Pathogenesis of Opisthorchis viverrini-associated CCA\n## Anatomical Subtypes and Clinical Implications","[{\"question\":\"Why are stage-specific biomarkers important for Opisthorchis viverrini-induced cholangiocarcinoma?\",\"answer\":\"Stage-specific biomarkers support early detection and help monitor therapy effectiveness, enabling timely curative interventions and adjustments to reduce high morbidity and mortality.\"},{\"question\":\"What causes most cholangiocarcinoma cases in the region to be diagnosed at advanced stages?\",\"answer\":\"The document links advanced diagnosis and poor prognosis to the prevalent high-risk environment created by liver fluke infection, with progression driven by long-term infection and inflammation.\"},{\"question\":\"What types of biomarkers does the review discuss for OvCCA?\",\"answer\":\"The review discusses potential O. viverrini-specific molecular biomarkers for diagnosis and monitoring, including both worm-induced and host-induced factors, and evaluates their prognostic, predictive, and diagnostic roles.\"}]","Current State of Knowledge on Blood and Tissue-Based Biomarkers for Opisthorchis viverrini-induced Cholangiocarcinoma - A Review of Prognostic, Predictive, and Diagnostic Markers | PDF",1790013061,43]